CEO
Knight Therapeutics Inc.
Equibles does not estimate personal net worth.
Samira Sakia is recorded as CEO at Knight Therapeutics Inc.. Samira Sakia has spoken on 1 earnings call across 1 company, most recently for Knight Therapeutics Inc. on November 5, 2026. Knight Therapeutics Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Good morning, everyone, and welcome to Knight Therapeutics' third quarter 2026 conference call. I'm joined in today's call by Amal Khoury, our Chief Business Officer, and Arvind Uchina, our Chief Financial Officer.”
Knight Therapeutics Inc.
CEO
Transcript header (unverified)
Knight Therapeutics Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Knight Therapeutics' Third Quarter 2026 Results Conference Call
Knight Therapeutics Inc.
